Drug Price Controls Lead to Higher Costs, Fewer Choices

When the Biden administration announces its first round of price caps on prescription drugs this summer, Democrats will declare it a victory for patients. However, neither the price controls nor other drug provisions under the 2022 Inflation Reduction Act are anything to celebrate.

Read Full Article »


Comment
Show comments Hide Comments


Related Articles